Cancer Family
Malignant Genitourinary System Neoplasm
CI-CAN-00000233Explore in graph →
3,546 active trials61 approved drugs295 evidence items
- NCIt
- C156484
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000233Explore in graph →
Clinical trials
15,539 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,963)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02470741 | Pilot of Letrozole for Uterine Myomas(PLUM) | completed | Phase 4 | 12 | University of California, San FranciscoOTHER | 1 | Nov 15, 2019 | clinicaltrials |
| NCT01206764 | A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma. | completed | Phase 4 | 143 | Novartis PharmaceuticalsINDUSTRY | 10 | Jun 24, 2019 | clinicaltrials |
| NCT02837926 | Comparing Health Services Interventions for the Prevention of HPV-related Cancer(CoheaHr-WP4) | completed | Phase 4 | 63 | CHU de ReimsOTHER | 1 | Apr 10, 2019 | clinicaltrials |
| NCT01544478 | V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110) | completed | Phase 4 | 1,030 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Nov 28, 2018 | clinicaltrials |
| NCT03752606 | Application of Tachosil During Lymphadenectomy | completed | Phase 4 | 50 | Medical University of LublinOTHER | 1 | Nov 26, 2018 | clinicaltrials |
| NCT01136226 | Evaluate Recovery of Testosterone for Patients Using Eligard(Eligard) | completed | Phase 4 | 42 | Chesapeake Urology Research AssociatesOTHER | 0 | Oct 24, 2018 | clinicaltrials |
| NCT02818816 | Preoperative Brimonidine on IOP of Patients Undergoing RALP(IOPsTBURG) | completed | Phase 4 | 26 | University Health Network, TorontoOTHER | 1 | Sep 27, 2018 | clinicaltrials |
| NCT00859027 | Effect Of Risedronate On Bone Mass In Older Men Receiving Neoadjuvant Therapy For Prostate Cancer | completed | Phase 4 | 50 | UConn HealthOTHER | 1 | May 1, 2018 | clinicaltrials |
| NCT02214602 | Value of Immediate Post-operative Intravesical Epirubicin in Intermediate&High Risk Non Muscle Invasive Bladder Cancer(NMIBCIVT) | completed | Phase 4 | 240 | Mansoura UniversityOTHER | 1 | Mar 22, 2018 | clinicaltrials |
| NCT03384511 | The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies. | completed | Phase 4 | 38 | Shandong Cancer Hospital and InstituteOTHER | 1 | Feb 20, 2018 | clinicaltrials |
| NCT02025361 | Impact of Local Anesthesia Type on Cancer Detection Rate in Transrectal Ultrasound Guided Prostate Biopsy | completed | Phase 4 | 422 | Bagcilar Training and Research HospitalOTHER_GOV | 1 | Jan 18, 2018 | clinicaltrials |
| NCT00995878 | The FIRSTT: Comparing MRgFUS(MR-guided Focused Ultrasound) Versus UAE (Uterine Artery Embolization)for Uterine Fibroids. | completed | Phase 4 | 56 | Mayo ClinicOTHER | 1 | Jan 12, 2018 | clinicaltrials |
| NCT01266837 | Open Label, Single Arm Trial to Characterize Patients With Metastatic RCC Treated With Everolimus After Failure of the First VEGF-targeted Therapy (MARC-2)(MARC-2) | completed | Phase 4 | 64 | iOMEDICO AGINDUSTRY | 1 | Nov 14, 2017 | clinicaltrials |
| NCT00666978 | Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking | completed | Phase 4 | 540 | Lisa Sanderson Cox, PhDOTHER | 1 | Nov 13, 2017 | clinicaltrials |
| NCT01296672 | 3 Month Finasteride Challenge Test Can Significantly Improve the Performance of Screening for Prostate Cancer | completed | Phase 4 | 383 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Oct 6, 2017 | clinicaltrials |
| NCT00063609 | The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy | completed | Phase 4 | 200 | Novartis PharmaceuticalsINDUSTRY | 1 | Sep 13, 2017 | clinicaltrials |
| NCT01521715 | First Line Pazopanib in Poor Risk Patients With Metastatic Renal Cell Carcinoma(FLIPPER) | completed | Phase 4 | 44 | iOMEDICO AGINDUSTRY | 1 | Aug 23, 2017 | clinicaltrials |
| NCT01514448 | Safety and Efficacy of Everolimus in Metastatic Renal Cell Carcinoma After Failure of First Line Therapy With Sunitinib or Pazopanib | completed | Phase 4 | 29 | Novartis PharmaceuticalsINDUSTRY | 1 | Jul 19, 2017 | clinicaltrials |
| NCT03174912 | In the Prediction of Recurrence and Progression of NMIBC; EORTC or CUETO or Both? | completed | Phase 4 | 400 | Ankara Training and Research HospitalOTHER | 0 | Jun 5, 2017 | clinicaltrials |
| NCT00219271 | Effect Of Zoledronic Acid On Circulating And Bone Marrow-Residing Prostate Cancer Cells In Patients With Clinically Localized Prostate Cancer | completed | Phase 4 | 60 | Novartis PharmaceuticalsINDUSTRY | 1 | May 31, 2017 | clinicaltrials |
| NCT02988219 | Cardiac Arrhythmias in Patients Undergoing Kidney Cancer Surgery Depending on the Anaesthesia Method | completed | Phase 4 | 50 | Medical University of WarsawOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT01230905 | Study to Monitor the Effects of Androgen Suppression Treatment on the Heart(AST) | completed | Phase 4 | 181 | Ottawa Heart Institute Research CorporationOTHER | 1 | Apr 24, 2017 | clinicaltrials |
| NCT01432015 | Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting | completed | Phase 4 | 20 | Gynecologic Oncology AssociatesOTHER | 1 | Mar 28, 2017 | clinicaltrials |
| NCT00237146 | Study to Evaluate Zoledronic Acid on Quality of Life and Skeletal-related Events as Adjuvant Treatment in Patients With Hormone-naïve Prostate Cancer and Bone Metastasis Who Have Undergone Orchiectomy | completed | Phase 4 | 38 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 23, 2017 | clinicaltrials |
| NCT00242554 | Open-label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastases | completed | Phase 4 | 150 | Novartis PharmaceuticalsINDUSTRY | 0 | Feb 23, 2017 | clinicaltrials |
| NCT00334139 | Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer | completed | Phase 4 | 411 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 7, 2017 | clinicaltrials |
| NCT02441894 | Combination of Cabazitaxel With Prednisolone With Primary Prophylaxis With PEG-G-CSF in Treatment of Patients With Prostate Cancer(PEGAZUS) | completed | Phase 4 | 21 | SanofiINDUSTRY | 1 | Jan 24, 2017 | clinicaltrials |
| NCT00375765 | Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer | completed | Phase 4 | 40 | GlaxoSmithKlineINDUSTRY | 1 | Jan 19, 2017 | clinicaltrials |
| NCT01571544 | The Use of Thermal Suits as Preventing Hypothermia During Surgery | completed | Phase 4 | 100 | Tampere University HospitalOTHER | 1 | Jan 4, 2017 | clinicaltrials |
| NCT00172003 | Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis | completed | Phase 4 | 50 | Novartis PharmaceuticalsINDUSTRY | 1 | Nov 18, 2016 | clinicaltrials |
| NCT00391690 | Evaluation of Bone Markers as Diagnostic Tools for Early Detection of Bone Metastases in Patients With High Risk Prostate Cancer | completed | Phase 4 | 99 | NovartisINDUSTRY | 1 | Nov 18, 2016 | clinicaltrials |
| NCT01388907 | Efficacity Assessment of PREVADH® in Adhesion Prevention in Gynaecologic Surgery | completed | Phase 4 | 61 | Medtronic - MITGINDUSTRY | 1 | Nov 17, 2016 | clinicaltrials |
| NCT00220194 | A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate Cancer | completed | Phase 4 | 100 | San Bernardino Urological Associates Medical Group IncOTHER | 1 | Oct 14, 2016 | clinicaltrials |
| NCT00817479 | Tumor Gene Expression in Women With Ovarian Cancer | completed | Phase 4 | 20 | University of ChicagoOTHER | 1 | Jul 13, 2016 | clinicaltrials |
| NCT01649635 | Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer(PROSPECTA) | completed | Phase 4 | 45 | SanofiINDUSTRY | 1 | Jul 6, 2016 | clinicaltrials |
| NCT00613275 | Patient Navigation in the Safety Net:CONNECTeDD | completed | Phase 4 | 4,038 | Boston Medical CenterOTHER | 1 | Jun 15, 2016 | clinicaltrials |
| NCT02773251 | The Effect of Guardix-solution for the Prevention of Postoperative Intestinal Adhesion and Intestinal Obstruction After Laparoscopic Pelvic Cavity Surgery | completed | Phase 4 | 60 | Bucheon St. Mary's HospitalOTHER | 0 | May 17, 2016 | clinicaltrials |
| NCT01083199 | Global Performance Evaluation of the AMS CONTINUUM™ Device | completed | Phase 4 | 10 | American Medical SystemsINDUSTRY | 2 | Apr 12, 2016 | clinicaltrials |
| NCT00365508 | Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking | completed | Phase 4 | 642 | Fox Chase Cancer CenterOTHER | 1 | Mar 29, 2016 | clinicaltrials |
| NCT01402089 | Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients | completed | Phase 4 | 54 | Markus JoergerOTHER | 1 | Feb 2, 2016 | clinicaltrials |
| NCT02102646 | MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism | completed | Phase 4 | 31 | Herlev HospitalOTHER | 1 | Oct 28, 2015 | clinicaltrials |
| NCT01511874 | Efficacy and Safety Study of ELIGARD 22.5mg With Prostate Cancer | completed | Phase 4 | 42 | HanAll BioPharma Co., Ltd.INDUSTRY | 1 | Sep 23, 2015 | clinicaltrials |
| NCT02149628 | The Effect of Propofol Based Total Intravenous Anesthesia on Oxidative Stress and Nitric Oxide | completed | Phase 4 | 50 | Yonsei UniversityOTHER | 1 | Jul 29, 2015 | clinicaltrials |
| NCT00219219 | Zoledronic Acid in the Prevention of Skeletal-related Events in Hormone Refractory and Hormone-sensitive Prostate Cancer Patients With Bone Metastases | completed | Phase 4 | — | NovartisINDUSTRY | 1 | Apr 14, 2015 | clinicaltrials |
| NCT00862810 | Alternate Dosing Schedules Study for HPV Vaccine(ADS) | completed | Phase 4 | 72 | Duke UniversityOTHER | 1 | Nov 20, 2014 | clinicaltrials |
| NCT02296255 | Effect of HPV Vaccination on Women Aged 25 Years | completed | Phase 4 | 832 | Cancer Prevention and Research Institute, ItalyOTHER | 1 | Nov 20, 2014 | clinicaltrials |
| NCT01492179 | Intravenous or Intra-abdominal Local Anesthetics for Postoperative Pain Management.(PoPuLAR) | completed | Phase 4 | 60 | Örebro University, SwedenOTHER | 1 | May 28, 2014 | clinicaltrials |
| NCT00805701 | Study Assessing The Efficacy And Safety Of Avodart (Dutasteride) At Improving Urinary Symptoms In Men With Prostate Cancer Who Are Undergoing Seed Implantation | completed | Phase 4 | 40 | Bay State Clinical Trials, Inc.OTHER | 1 | May 14, 2014 | clinicaltrials |
| NCT02056587 | Everolimus in Patients With Metastatic Renal Cell Carcinoma Following Progression on Prior Bevacizumab Treatment | completed | Phase 4 | 37 | Kidney Cancer Research BureauOTHER | 1 | Feb 6, 2014 | clinicaltrials |
| NCT00006864 | Interleukin-2 in Treating Patients With Metastatic Kidney Cancer | completed | Phase 4 | — | Case Comprehensive Cancer CenterOTHER | 1 | Jan 9, 2014 | clinicaltrials |
Data updated 23 days agoSource updated Nov 15, 2019source: clinicaltrials